Apellis Pharmaceuticals, Inc. (APLS) received a Neutral rating from Douglas Tsao at HC Wainwright & Co., suggesting a cautious stance amid a turbulent market. At a current price of $40.39, this rating ...

Citigroup analyst Patrick Cunningham reasserted a Neutral rating for PPG Industries, Inc. (NYSE: PPG), reflecting cautious optimism as the stock hovers at $106.88, just shy of a price target of $113.

In a noteworthy update for investors, Theriva Biologics, Inc. (TOVX) has received a Buy rating from Jason McCarthy of Maxim Group as of. This recommendation comes at a time when the stock is priced at ...

Terns Pharmaceuticals, Inc. (NASDAQ: TERN), a biotechnology firm focused on developing therapeutics for liver diseases, has been rated as a ‘Hold’ by Truist Securities analyst Srikripa Devarakonda.

Riskified (RSKD) and Alarum (ALAR): two debt-free small-cap AI stocks hitting record revenue in 2026. Here's what investors ...

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) recently caught the attention of investors as Barclays analyst Etzer Darout issued an Equal-Weight rating on March 30, 2026, with a price target set at $53.

Telecom Argentina S.A. (TEO) has recently been downgraded to a “Sector Underperform” by Scotiabank analyst Andres Coello. This change, marked on March 30, 2026, comes amidst a backdrop of fluctuating ...

The Scotts Miracle-Gro Company (NYSE: SMG) is facing a critical juncture as noted by Jeffrey Zekauskas of JP Morgan, who recently adjusted the stock’s rating to Neutral. This shift, announced on March ...

TWLO and FLYW hit GAAP profitability in 2025. Are they the best digital stocks to buy in 2026? Here's what investors need to ...

Nutrien Ltd. (NTR) was downgraded to a “Sell” rating by UBS analyst Lucas Beaumont, with a price target set at $67—substantially underneath the current trading price of $76.62. This rating shift has ...

Wheaton Precious Metals Corp. (NYSE: WPM) received a fresh “Buy” rating from Daniel Major of UBS, indicating a bullish outlook for the stock. With a price target set at $160, investors are presented ...

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) saw its stock rating downgraded to Neutral by analyst Andres Y. Maldonado of HC Wainwright & Co. on March 25, 2026. With a current share price of $50, the ...